Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort

Systemic Lupus Erythematosus

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Arthritis Res Ther

Su Z, Zhang C, Gao C, Li C, Li R, Zheng Z

doi: 10.1186/s13075-024-03389-4

Systemic Lupus Erythematosus

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Semin Arthritis Rheum

González LA, Harvey GB, Quintana R, Pons-Estel GJ, Ugarte-Gil MF, Vásquez G, Catoggio LJ, García MA, Borba EF, Da Silva NA, Brenol JCT, Toledano MG, Massardo L, Neira O, Pascual-Ramos V, Amigo MC, Barile-Fabris LA, Torre IG, Alfaro-Lozano J, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Iglesias-Gamarra A, Alarcón GS, Pons-Estel BA

doi: 10.1016/j.semarthrit.2024.152568

Systemic Lupus Erythematosus

Modelling long-term outcomes for patients with systemic lupus erythematosus

Semin Arthritis Rheum

Touma Z, Kayaniyil S, Parackal A, Bonilla D, Su J, Johnston A, Gahn J, Hille ED, Ohsfeldt R, Chandran S

doi: 10.1016/j.semarthrit.2024.152507

Systemic Lupus Erythematosus

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

Rheumatology (Oxford)

Katechis S, Nikolopoulos D, Flouda S, Adamichou C, Chavatza K, Kapsala N, Katsimbri P, Bertsias G, Boumpas DT, Fanouriakis A

doi: 10.1093/rheumatology/keae278

Vitiligo

Real-world evidence for vitiligo using an electronic medical records database in Spain: the REVEAL-ES study

Eur J Dermatol

Estebaranz JLL, González-Montagut CM, González J, Miguel IAGS, Garcia-Recio V, Callejo D, De Prado A, Delattre C

doi: 10.1684/ejd.2024.4676

Systemic Lupus Erythematosus

Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study

J Rheumatol

Ichikawa T, Kishida D, Shimojima Y, Yajima N, Oguro N, Yoshimi R, Sakurai N, Hidekawa C, Sada KE, Miyawaki Y, Hayashi K, Shidahara K, Ishikawa Y, Sekijima Y, Kurita N

doi: 10.3899/jrheum.2024-1088

Osteoarthritis

Osteoarthritis across Joint Sites in the Million Veteran Program Cohort: Insights from Electronic Health Records and Military Service History

J Rheumatol

Lavin KM, Richman JS, McDonald MN, Singh JA

doi: 10.3899/jrheum.2024-0237

Systemic Lupus Erythematosus

Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Arthritis Rheumatol

Ma KS, Lo JE, Kyttaris VC, Tsokos GC, Costenbader KH

doi: 10.1002/art.43037

Systemic Sclerosis

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Rheumatology (Oxford)

Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, Mageed R, Ong VH

doi: 10.1093/rheumatology/keaf006

Related content

Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study

Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

Modelling long-term outcomes for patients with systemic lupus erythematosus

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

Real-world evidence for vitiligo using an electronic medical records database in Spain: the REVEAL-ES study

Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study

Osteoarthritis across Joint Sites in the Million Veteran Program Cohort: Insights from Electronic Health Records and Military Service History

Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis